ABIO logo

ARCA Biopharma (ABIO) Cash From Investing

Annual CFI

$0.00
+$2000.00+100.00%

December 31, 2023

Summary

Performance

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

-100%

15-Year Change

-100%

ABIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$45.63 M
ABIO annual cash flow from investing activities is currently -100.00% below its historical high of $45.63 million

3-Year Low

-$43.00 K

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIOcash flowmetrics:

Annual CFF

$0.00
ABIO annual cash flow from financing activities is $0.00

Annual CFO

-$5.01 M
ABIO annual cash flow from operations is -$5.01 million

Annual FCF

-$5.01 M
ABIO annual free cash flow is -$5.01 million

Annual CAPEX

-
ABIO annual capital expenditures value is unknown

Quarterly CFI

$0.00
$0.000.00%

June 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+100%

5-Year Change

+100%

ABIO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$42.23 M
ABIO quarterly cash flow from investing activities is currently -100.00% below its historical high of $42.23 million

3-Year Low

-$7000.00

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIOcash flowmetrics:

Quarterly CFF

$14.00 K
ABIO quarterly cash flow from financing activities is $14.00 thousand

Quarterly CFO

-$2.63 M
ABIO quarterly cash flow from operations is -$2.63 million

Quarterly FCF

-$2.63 M
ABIO quarterly free cash flow is -$2.63 million

Quarterly CAPEX

-
ABIO quarterly capital expenditures value is unknown

TTM CFI

$0.00
$0.000.00%

June 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+100%

5-Year Change

+100%

ABIO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$45.63 M
ABIO TTM cash flow from investing activities is currently -100.00% below its historical high of $45.63 million

3-Year Low

-$43.00 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIOcash flowmetrics:

TTM CFF

$14.00 K
ABIO TTM cash flow from financing activities is $14.00 thousand

TTM CFO

-$6.89 M
ABIO TTM cash flow from operations is -$6.89 million

TTM FCF

-$6.89 M
ABIO TTM free cash flow is -$6.89 million

TTM CAPEX

-
ABIO TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ABIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%0.0%0.0%
3 y3 years+100.0%+100.0%+100.0%
5 y5 years-100.0%+100.0%+100.0%

ABIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high<-9999.0%at high<-9999.0%at high<-9999.0%
5 y5-yearat high<-9999.0%at high<-9999.0%at high<-9999.0%
alltimeall time-100.0%<-9999.0%-100.0%<-9999.0%-100.0%<-9999.0%

ARCA Biopharma Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2024
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2022
-$2000.00(-95.3%)
$0.00(0.0%)
-$2000.00(-77.8%)
Sep 2022
-
$0.00(0.0%)
-$9000.00(-60.9%)
Jun 2022
-
$0.00(-100.0%)
-$23.00 K(-41.0%)
Mar 2022
-
-$2000.00(-71.4%)
-$39.00 K(-9.3%)
Dec 2021
-$43.00 K(+126.3%)
-$7000.00(-50.0%)
-$43.00 K(-12.2%)
Sep 2021
-
-$14.00 K(-12.5%)
-$49.00 K(+40.0%)
Jun 2021
-
-$16.00 K(+166.7%)
-$35.00 K(+59.1%)
Mar 2021
-
-$6000.00(-53.8%)
-$22.00 K(+15.8%)
Dec 2020
-$19.00 K(+375.0%)
-$13.00 K(<-9900.0%)
-$19.00 K(+137.5%)
Sep 2020
-
$0.00(-100.0%)
-$8000.00(-20.0%)
Jun 2020
-
-$3000.00(0.0%)
-$10.00 K(+42.9%)
Mar 2020
-
-$3000.00(+50.0%)
-$7000.00(+75.0%)
Dec 2019
-$4000.00(-100.1%)
-$2000.00(0.0%)
-$4000.00(+100.0%)
Sep 2019
-
-$2000.00(<-9900.0%)
-$2000.00(-33.3%)
Jun 2019
-
$0.00(0.0%)
-$3000.00(0.0%)
Mar 2019
-
$0.00(0.0%)
-$3000.00(-100.1%)
Dec 2018
$3.05 M(-76.4%)
$0.00(-100.0%)
$3.05 M(-60.9%)
Sep 2018
-
-$3000.00(<-9900.0%)
$7.79 M(+13.5%)
Jun 2018
-
$0.00(-100.0%)
$6.87 M(-47.1%)
Mar 2018
-
$3.05 M(-35.8%)
$12.97 M(+0.3%)
Dec 2017
$12.93 M(-178.7%)
$4.75 M(-609.5%)
$12.93 M(+14.1%)
Sep 2017
-
-$932.00 K(-115.3%)
$11.32 M(+16.6%)
Jun 2017
-
$6.10 M(+102.8%)
$9.71 M(-218.3%)
Mar 2017
-
$3.01 M(-4.4%)
-$8.20 M(-50.0%)
Dec 2016
-$16.41 M(>+9900.0%)
$3.15 M(-223.5%)
-$16.41 M(-16.1%)
Sep 2016
-
-$2.55 M(-78.4%)
-$19.56 M(+15.0%)
Jun 2016
-
-$11.81 M(+127.1%)
-$17.02 M(+226.6%)
Mar 2016
-
-$5.20 M(>+9900.0%)
-$5.21 M(>+9900.0%)
Dec 2015
-$11.00 K(-42.1%)
-$2000.00(0.0%)
-$11.00 K(-52.2%)
Sep 2015
-
-$2000.00(-60.0%)
-$23.00 K(+9.5%)
Jun 2015
-
-$5000.00(+150.0%)
-$21.00 K(0.0%)
Mar 2015
-
-$2000.00(-85.7%)
-$21.00 K(+10.5%)
Dec 2014
-$19.00 K(-40.6%)
-$14.00 K(<-9900.0%)
-$19.00 K(+111.1%)
Sep 2014
-
$0.00(-100.0%)
-$9000.00(-55.0%)
Jun 2014
-
-$5000.00(<-9900.0%)
-$20.00 K(-13.0%)
Mar 2014
-
$0.00(-100.0%)
-$23.00 K(-28.1%)
Dec 2013
-$32.00 K(<-9900.0%)
-$4000.00(-63.6%)
-$32.00 K(+18.5%)
Sep 2013
-
-$11.00 K(+37.5%)
-$27.00 K(+68.8%)
Jun 2013
-
-$8000.00(-11.1%)
-$16.00 K(+77.8%)
Mar 2013
-
-$9000.00(-1000.0%)
-$9000.00(<-9900.0%)
Dec 2012
$0.00(-100.0%)
$1000.00(>+9900.0%)
$0.00(-100.0%)
Sep 2012
-
$0.00(-100.0%)
$4000.00(-20.0%)
Jun 2012
-
-$1000.00(<-9900.0%)
$5000.00(-99.8%)
Mar 2012
-
$0.00(-100.0%)
$2.01 M(0.0%)
Dec 2011
$2.01 M(+657.0%)
$5000.00(+400.0%)
$2.01 M(-11.3%)
Sep 2011
-
$1000.00(-100.0%)
$2.26 M(+0.0%)
Jun 2011
-
$2.00 M(>+9900.0%)
$2.26 M(+746.8%)
Mar 2011
-
$0.00(-100.0%)
$267.00 K(+0.8%)
Dec 2010
$265.00 K
$261.00 K(>+9900.0%)
$265.00 K(+1556.3%)
DateAnnualQuarterlyTTM
Sep 2010
-
$0.00(-100.0%)
$16.00 K(-99.7%)
Jun 2010
-
$6000.00(-400.0%)
$5.11 M(-46.2%)
Mar 2010
-
-$2000.00(-116.7%)
$9.49 M(-79.2%)
Dec 2009
$45.63 M(-1907.3%)
$12.00 K(-99.8%)
$45.63 M(+2288.0%)
Sep 2009
-
$5.09 M(+16.0%)
$1.91 M(-95.1%)
Jun 2009
-
$4.39 M(-87.9%)
$39.05 M(+242.6%)
Mar 2009
-
$36.14 M(-182.7%)
$11.40 M(-551.4%)
Dec 2008
-$2.52 M(-112.0%)
-$43.71 M(-203.5%)
-$2.52 M(-106.0%)
Sep 2008
-
$42.23 M(-281.5%)
$41.96 M(+467.0%)
Jun 2008
-
-$23.26 M(-204.7%)
$7.40 M(-60.4%)
Mar 2008
-
$22.22 M(+2777.8%)
$18.69 M(-11.4%)
Dec 2007
$21.09 M(-134.0%)
$772.00 K(-89.9%)
$21.09 M(-217.9%)
Sep 2007
-
$7.67 M(-164.1%)
-$17.88 M(-50.5%)
Jun 2007
-
-$11.97 M(-148.6%)
-$36.12 M(+2.3%)
Mar 2007
-
$24.61 M(-164.4%)
-$35.29 M(-43.1%)
Dec 2006
-$62.06 M(+5182.0%)
-$38.20 M(+261.7%)
-$62.06 M(+295.7%)
Sep 2006
-
-$10.56 M(-5.2%)
-$15.68 M(+289.2%)
Jun 2006
-
-$11.14 M(+415.5%)
-$4.03 M(-255.0%)
Mar 2006
-
-$2.16 M(-126.4%)
$2.60 M(-321.3%)
Dec 2005
-$1.18 M(-91.3%)
$8.18 M(+648.8%)
-$1.18 M(-104.7%)
Sep 2005
-
$1.09 M(-124.2%)
$25.23 M(+54.6%)
Jun 2005
-
-$4.51 M(-24.0%)
$16.32 M(-160.4%)
Mar 2005
-
-$5.94 M(-117.2%)
-$27.01 M(+98.9%)
Dec 2004
-$13.58 M(-147.8%)
$34.59 M(-542.7%)
-$13.58 M(-79.1%)
Sep 2004
-
-$7.81 M(-83.7%)
-$64.86 M(+17.7%)
Jun 2004
-
-$47.85 M(-738.5%)
-$55.09 M(-2093.0%)
Mar 2004
-
$7.49 M(-144.9%)
$2.76 M(-90.3%)
Dec 2003
$28.39 M(-1518.9%)
-$16.70 M(-950.6%)
$28.39 M(-36.8%)
Sep 2003
-
$1.96 M(-80.4%)
$44.90 M(+5.1%)
Jun 2003
-
$10.01 M(-69.8%)
$42.72 M(+32.7%)
Mar 2003
-
$33.12 M(<-9900.0%)
$32.19 M(-1708.6%)
Dec 2002
-$2.00 M(-84.1%)
-$189.00 K(-14.1%)
-$2.00 M(-71.0%)
Sep 2002
-
-$220.00 K(-58.0%)
-$6.89 M(-29.4%)
Jun 2002
-
-$524.00 K(-50.9%)
-$9.76 M(-10.0%)
Mar 2002
-
-$1.07 M(-79.0%)
-$10.84 M(-13.8%)
Dec 2001
-$12.58 M(-244.1%)
-$5.08 M(+64.5%)
-$12.58 M(+59.4%)
Sep 2001
-
-$3.09 M(+91.7%)
-$7.89 M(+1520.7%)
Jun 2001
-
-$1.61 M(-42.6%)
-$487.00 K(-89.5%)
Mar 2001
-
-$2.81 M(+621.6%)
-$4.63 M(-153.0%)
Dec 2000
$8.73 M(+149.5%)
-$389.00 K(-109.0%)
$8.73 M(+67.2%)
Sep 2000
-
$4.32 M(-175.1%)
$5.22 M(+68.3%)
Jun 2000
-
-$5.75 M(-154.5%)
$3.10 M(-73.8%)
Mar 2000
-
$10.55 M(-370.6%)
$11.85 M(+238.7%)
Dec 1999
$3.50 M(-22.2%)
-$3.90 M(-277.3%)
$3.50 M(-75.4%)
Sep 1999
-
$2.20 M(-26.7%)
$14.20 M(-10.1%)
Jun 1999
-
$3.00 M(+36.4%)
$15.80 M(-644.8%)
Mar 1999
-
$2.20 M(-67.6%)
-$2.90 M(-164.4%)
Dec 1998
$4.50 M(-112.1%)
$6.80 M(+78.9%)
$4.50 M(-131.5%)
Sep 1998
-
$3.80 M(-124.2%)
-$14.30 M(-66.0%)
Jun 1998
-
-$15.70 M(-263.5%)
-$42.10 M(+54.2%)
Mar 1998
-
$9.60 M(-180.0%)
-$27.30 M(-26.4%)
Dec 1997
-$37.10 M(+4022.2%)
-$12.00 M(-50.0%)
-$37.10 M(+47.8%)
Sep 1997
-
-$24.00 M(+2566.7%)
-$25.10 M(+2181.8%)
Jun 1997
-
-$900.00 K(+350.0%)
-$1.10 M(+450.0%)
Mar 1997
-
-$200.00 K
-$200.00 K
Dec 1996
-$900.00 K
-
-

FAQ

  • What is ARCA biopharma annual cash flow from investing activities?
  • What is the all time high annual CFI for ARCA biopharma?
  • What is ARCA biopharma annual CFI year-on-year change?
  • What is ARCA biopharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ARCA biopharma?
  • What is ARCA biopharma quarterly CFI year-on-year change?
  • What is ARCA biopharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ARCA biopharma?
  • What is ARCA biopharma TTM CFI year-on-year change?

What is ARCA biopharma annual cash flow from investing activities?

The current annual CFI of ABIO is $0.00

What is the all time high annual CFI for ARCA biopharma?

ARCA biopharma all-time high annual cash flow from investing activities is $45.63 M

What is ARCA biopharma annual CFI year-on-year change?

Over the past year, ABIO annual cash flow from investing activities has changed by +$2000.00 (+100.00%)

What is ARCA biopharma quarterly cash flow from investing activities?

The current quarterly CFI of ABIO is $0.00

What is the all time high quarterly CFI for ARCA biopharma?

ARCA biopharma all-time high quarterly cash flow from investing activities is $42.23 M

What is ARCA biopharma quarterly CFI year-on-year change?

Over the past year, ABIO quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is ARCA biopharma TTM cash flow from investing activities?

The current TTM CFI of ABIO is $0.00

What is the all time high TTM CFI for ARCA biopharma?

ARCA biopharma all-time high TTM cash flow from investing activities is $45.63 M

What is ARCA biopharma TTM CFI year-on-year change?

Over the past year, ABIO TTM cash flow from investing activities has changed by $0.00 (0.00%)